| Financial Year |
March 31 2023 |
| Monetary Funds |
1,380,226,987.37 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
85,805,922.58 |
| Accounts Receivable |
6,458,794,950.25 |
| Advances to Suppliers |
591,905,007.01 |
| Other Receivables |
514,952,386.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
8,286,759,797.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
78,681,678.04 |
| Other Current Assets |
82,698,321.54 |
| Total Current Assets |
18,228,529,701.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
240,620,570.53 |
| Long-term Equity Investment |
247,378,309.29 |
| Investment Properties |
21,380,863.52 |
| Fixed Assetes |
405,151,961.58 |
| Under-construction Projects |
285,696,125.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
176,478,254.24 |
| R&D expenses |
-- |
| Goodwill |
639,832,449.54 |
| Long-Term Deferred and Prepaid Expenses |
8,710,605.11 |
| Deferred Income Tax Assets |
109,540,707.83 |
| Other Non-Current Assets |
2,470,778.96 |
| Sub-Total of Non-Current Assets |
3,223,469,883.89 |
| Total Assets |
21,451,999,584.95 |
| Short-Term Loans |
3,643,293,858.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
45,967,372.55 |
| Accounts Payable |
2,072,165,831.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,731,725.95 |
| Taxes Payable |
61,320,448.52 |
| Interest Payable |
-- |
| Dividend Payable |
439,970,267.02 |
| Other payables |
1,374,325,571.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
48,852,901.83 |
| Other Current Liabilities |
245,193,554.33 |
| Sub-Total of Current Liabilities |
9,706,540,080.91 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,905,172.75 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
18,954,959.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
158,091,331.83 |
| Total Liabilities |
9,864,631,412.74 |
| Paid-In Capital(Or Share Stock) |
3,205,482,375.00 |
| Capital Surplus |
2,750,385,344.01 |
| Surplus Reserve |
803,663,186.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,522,650,340.66 |
| Minority Stockholder's Interest |
304,083,687.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,283,284,484.50 |
| Owner's Equity（Stockholder's Equity） |
11,587,368,172.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,451,999,584.95 |
